Paola Di Fiore

Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · The Journal of Headache and Pain · 2021 · 150 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)

Piero Barbanti, Gabriella Egeo, Cinzia Aurilia et al. · The Journal of Headache and Pain · 2022 · 103 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3‐month observational, longitudinal, cohort, multicenter, Italian real‐life study

Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli et al. · European Journal of Neurology · 2021 · 76 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +17

Transcutaneous supraorbital neurostimulation for the prevention of chronic migraine: a prospective, open-label preliminary trial

Paola Di Fiore, Gennaro Bussone, Alberto Galli et al. · Neurological Sciences · 2017 · 68 citations

Medicine, Neurological Surgery, Neurology +15

Late Response to Anti-CGRP Monoclonal Antibodies in Migraine

Piero Barbanti, Cinzia Aurilia, Gabriella Egeo et al. · Neurology · 2023 · 64 citations · Full text

Pharmacy, Neurology, Pharmacology +17